Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization

• Principais autores: Noha N. Atia (Autor), Hesham M. Tawfeek (Autor), Azza H. Rageh (Autor), Marwa R. El-Zahry (Autor), Ahmed Abdelfattah (Autor), Mahmoud A. Younis (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2019-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Ischemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate sublingual tablets containing a novel combination of Atorvastatin calcium (ATOR) and Trimetazidine HCl (TMZ) for efficient treatment...